How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?

Area of Science:

• Respiratory Medicine
• Allergy and Immunology
• Biomarker Research

Background:

• Asthma is a complex respiratory condition with diverse inflammatory and functional endotypes.
• Non-invasive biomarkers are being explored to understand asthma pathobiology.
• A clinical algorithm by Heany et al. uses peripheral blood eosinophil counts (PBE), FeNO, nasal polyps, and age of onset to classify severe asthma into likely eosinophilic phenotypes.

Purpose of the Study:

• To evaluate the concordance of the Heany et al. algorithm with sputum examination in classifying asthma phenotypes.
• To determine if non-invasive biomarkers can reliably identify eosinophilic asthma.

Main Methods:

• The study involved 145 asthma patients from the MEGA cohort with varying severity.
• The Heany et al. algorithm's classification was compared against sputum eosinophil counts, considered the gold standard.

Main Results:

• There was no significant correlation found between the algorithm's classification and sputum eosinophilia (p=0.025).
• No relationship was observed between sputum eosinophilia and peripheral blood eosinophil counts in the overall study population.

Conclusions:

• The combination of biomarkers in the Heany et al. algorithm is insufficient for diagnosing eosinophilic asthma phenotypes.
• Sputum analysis remains the definitive method for assessing airway inflammation in asthma.